Skip to main content
SCONRES 33 108th Congress Senate

A concurrent resolution expressing the sense of the Congress regarding scleroderma.

Introduced: October 8, 2004 See on congress.gov
Health Autoimmune diseasesCommemorationsCommunication in medicineCommunication in science
More subjectsShow fewer subjects
ConferencesCongressCongressional tributesEconomics and Public FinanceEnvironmental ProtectionEnvironmental researchEnvironmentally induced diseasesEpidemiologyFederal aid to researchGenetic researchGeneticsGovernment Operations and PoliticsHealth educationMedical researchPrescription pricing
Sign in to write a letter Sign in to watch
This resolution expired with the 108th Congress
It was not agreed to before the 108th Congress (2003–2004) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Apr 7, 2003
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4909-4910)
Apr 7, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 7, 2003

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4909-4910)

 Plain-English summary Congressional Research Service
Calls for: (1) recognition of private organizations and health care providers for promoting awareness and research on scleroderma; (2) greater awareness of the symptoms of scleroderma and contributions to the fight against it; (3) the National Institutes of Health to continue to take a leadership role in research efforts regarding the fight against scleroderma and to allow for broad dissemination of the information learned from such research; and (4) the Centers for Disease Control and Prevention to consider additional methods to improve disease surveillance of scleroderma.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 3 Republican 1
D
Durbin, Richard J.
Illinois · Oct 8, 2004
 D
Murray, Patty
Washington · Jul 21, 2004
 R
Crapo, Mike
Idaho · Sep 29, 2003
 D
Cantwell, Maria
Washington · Jul 7, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). S. Con. Res. 33: A concurrent resolution expressing the sense of the Congress regarding scleroderma.. 108th Congress. Open America. https://openamerica.io/bill/108-SCONRES-33/
MLA
"S. Con. Res. 33: A concurrent resolution expressing the sense of the Congress regarding scleroderma.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-SCONRES-33/.
Bluebook (legal)
S. Con. Res. 33, 108th Cong. (2026), https://openamerica.io/bill/108-SCONRES-33/.
Markdown link
[S. Con. Res. 33: A concurrent resolution expressing the sense of the Congress regarding scleroderma.](https://openamerica.io/bill/108-SCONRES-33/)
Report a problem